Document Detail


Laparoscopic Sleeve Gastrectomy: With or without Duodenal Switch? A Consecutive Series of 800 Cases.
MedLine Citation:
PMID:  24819497     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background: Sleeve gastrectomy (SG) was originally performed as the restrictive and acid-reducing part of a biliopancreatic diversion with duodenal switch (BPD-DS). It is now recognized as a stand-alone procedure, but direct comparison between the two procedures is still lacking. The goal of this study is to compare the outcomes of the two procedures and their respective impact on obesity-related comorbidities. Methods: All patients who had a laparoscopic SG (n = 378) or a laparoscopic BPD-DS (n = 422) before 10/2011 were included in this study (n = 800). Data were obtained from our prospectively maintained electronic database and are reported as mean ± standard deviation comparing SG with BPD-DS patients. Results: SG patients were older (48 ± 11 vs. 40 ± 10 years, p < 0.001) with a higher prevalence of comorbidities (type 2 diabetes mellitus in 51 vs. 37%; hypertension 62 vs. 49%; sleep apnea 63 vs. 51%; all p < 0.001). Initial BMI was 48 ± 9 vs. 48 ± 6 (p = 0.8). There was one 30-day mortality in the BPD-DS group, from a pulmonary embolism, for an overall mortality rate of 0.13%. Thirty-day complications occurred in 6 vs. 8% of patients (p = 0.2), including gastric leaks in 4 (1%) vs. 0 patients (p = 0.049). Mean follow-up was 29 ± 10 months. Excess weight loss was 45 ± 14 vs. 62 ± 15% at 6 months, 53 ± 18 vs. 81 ± 14% at 12 months, 53 ± 23 vs. 87 ± 15% at 18 months, 50 ± 19 vs. 86 ± 15% at 24 months and 51 ± 24 vs. 83 ± 16% at 36 months (p < 0.05 for all time points). The surgery induced the remission of type 2 diabetes mellitus in 56 vs. 90% of patients, hypertension in 54 vs. 76% and sleep apnea in 43 vs. 74% (all p < 0.05). In type 2 diabetic patients, fasting plasma glucose decreased by -1.9 mmol/l after SG vs. -2.9 mmol/l after BPD-DS (p < 0.05) and hemoglobin A1C by -1.1 vs. -1.9% (p < 0.05). Conclusion: SG results in a significant 3-year weight loss and remission of comorbidities. BPD-DS provides further improvement of associated comorbidities and can be an option for the management of insufficient weight loss or residual comorbidities following SG. © 2014 S. Karger AG, Basel.
Authors:
L Biertho; S Lebel; S Marceau; F S Hould; O Lescelleur; P Marceau; S Biron
Related Documents :
17903897 - The oxfordshire community stroke project classification: correlation with imaging, asso...
8170037 - The influence of anesthetic technique on perioperative complications after carotid enda...
24355257 - Cementless total knee arthroplasty in obese patients: a prospective matched study with ...
11244267 - Treatment of acute ischemic stroke: selecting the right treatment for the right patient.
3337947 - Complete rectal prolapse: the anatomical and functional results of treatment by an exte...
25280407 - Role of metabolic syndrome and antiretroviral therapy in adiponectin levels and oxidati...
Publication Detail:
Type:  Journal Article     Date:  2014-05-08
Journal Detail:
Title:  Digestive surgery     Volume:  31     ISSN:  1421-9883     ISO Abbreviation:  Dig Surg     Publication Date:  2014  
Date Detail:
Created Date:  2014-05-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8501808     Medline TA:  Dig Surg     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  48-54     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  State of the art: sleeve gastrectomy.
Next Document:  Novel/Experimental bariatric techniques.